Literature DB >> 21098319

Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma.

Piers Blombery1, H Miles Prince, Michele Levinson, Stephen Pianko, Ellen Maxwell, Prithi Bhathal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21098319     DOI： 10.1200/JCO.2010.31.8899

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Fulminant Colitis Following Rituximab Therapy.

Authors:  Seth Lipka; Seymour Katz; James M Crawford
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-01

2.  Adalimumab therapy in a patient with Crohn's disease with a giant pelvic paraganglioma after chemotherapy.

Authors:  Tsutomu Mizoshita; Masashi Ando; Hiroyuki Sagawa; Yoshinori Mori; Takahito Katano; Keiji Ozeki; Satoshi Tanida; Yasuyuki Okamoto; Takaya Shimura; Eiji Kubota; Hiromi Kataoka; Takeshi Kamiya; Takashi Joh
Journal:  Clin J Gastroenterol       Date:  2017-03-07

Review 3.  B cells and autoimmunity.

Authors:  Shiv Pillai; Hamid Mattoo; Annaiah Cariappa
Journal:  Curr Opin Immunol       Date:  2011-11-24       Impact factor: 7.486

Review 4.  Current stage in inflammatory bowel disease: What is next?

Authors:  Gonzalo Jesús Gómez-Gómez; Ángeles Masedo; Carmen Yela; Maria del Pilar Martínez-Montiel; Begoña Casís
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

Review 5.  Medication-associated gastrointestinal tract injury.

Authors:  Michael Vieth; Elizabeth Montgomery
Journal:  Virchows Arch       Date:  2017-01-30       Impact factor: 4.535

Review 6.  Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.

Authors:  Weixun Zhou; Yan Huang; Jinping Lai; Jun Lu; Michael Feely; Xiuli Liu
Journal:  Gastroenterology Res       Date:  2018-05-31

Review 7.  Rituximab-induced Ileocolitis in a Patient with Gastric MALToma: A Case Report and Literature Review.

Authors:  Yoshikazu Tsuzuki; Rie Shiomi; Keigo Ashitani; Kazuya Miyaguchi; Atsushi Osaki; Hideki Ohgo; Rei Kim; Atsushi Sasaki; Taketo Yamada; Yoshitaka Miyakawa; Hidetomo Nakamoto; Hiroyuki Imaeda
Journal:  Intern Med       Date:  2021-03-01       Impact factor: 1.271

8.  B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.

Authors:  Wilhelmina M C Timmermans; Jan A M van Laar; Tim B van der Houwen; Lieke S J Kamphuis; Sophinus J W Bartol; King H Lam; Rob J Ouwendijk; Miles P Sparrow; Peter R Gibson; P Martin van Hagen; Menno C van Zelm
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.